Protagonist Therapeutics, Inc Accrued Income Taxes, Current
Protagonist Therapeutics, Inc (PTGX) had Accrued Income Taxes, Current of $1.89 million as of 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-02-25
- 2025-03-31: Accrued Income Taxes, Current $1.89M.
- 2024-12-31: Accrued Income Taxes, Current $2.69M.
- 2024-09-30: Accrued Income Taxes, Current $1.05M.
- 2024-06-30: Accrued Income Taxes, Current $2.65M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2025-03-31 | $1.89M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $2.69M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.05M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.65M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $3.33M 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |